Background Chronic inflammatory demyelinating polyneuropathy (CIDP) is a potentially disabling health condition. Objective To assess the effects of different pharmacological interventions used in CIPD. Methods To summarize and to discuss… Click to show full abstract
Background Chronic inflammatory demyelinating polyneuropathy (CIDP) is a potentially disabling health condition. Objective To assess the effects of different pharmacological interventions used in CIPD. Methods To summarize and to discuss the rehabilitation perspective on the published Cochrane Overview "Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overviewof systematic reviews" by Anne Louise Oaklander, et al., representing the Cochrane Neuromuscular Group. Results Five CSRs and 23 RCTs, reporting data on corticosteroids, plasma exchange and intravenous immunoglobulin, were considered in the overview. Conclusions High quality trials investigating the combined effectiveness of drugs and exercise using ICF based outcomes should be encouraged.
               
Click one of the above tabs to view related content.